Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Vivani Medical, Inc.NASDAQ: VANI
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables falls 93.1% from a year ago
Net receivables stood at $12K at the end of Q1 FY2026, down 93.1% from a year earlier and down 98.2% from the prior quarter.
Context
- Net receivables amounted to 0.0% of total assets at the end of Q1 FY2026, down 0.5 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -93.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 654K USD
- Year-over-year change
- +158.5%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 654K | +158.5% |
| FY2024 | 2024-12-31 | 253K | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Net Receivables vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -93.1% is the lowest of 5, against a peer median of -10.2%.
- Net receivables amounts to 0.0% of total assets for VANI, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $88.99M USD | +9.0% | +7.7% | 40.6% | |
| Mar 2026 | $9.89M USD | -18.6% | +22.4% | 19.2% | |
| Mar 2026 | $5.8M USD | -20.2% | +27.7% | 9.6% | |
| Mar 2026 | CA$340.58K CAD | -1.8% | -13.9% | 1.1% | |
| Mar 2026 | $105K USD | — | +32.8% | 0.1% | |
| Mar 2026 | $12K USD | -93.1% | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
IMAImageneBio Inc | Mar 2026 | $0 USD | — | — | 0.0% |
| Peer median (excluding VANI) | — | -10.2% | +22.4% | 1.1% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.